General MedicationsINJECTIONStandard
DIPRIVAN
PROPOFOL
Standard Dose
10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview DIPRIVAN is listed in Drugs@FDA under application 019627 (NDA).
Review priority: N/A Marketing status: Prescription Active ingredient PROPOFOL Form and strength INJECTABLE;INJECTION - 10MG/ML Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-11-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview DIPRIVAN is listed in Drugs@FDA under application 019627 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient PROPOFOL Form and strength INJECTABLE;INJECTION - 10MG/ML Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-11-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.